More Business Wire
View Older Stories View Newer Stories-
ICE Reports Record Market Activity as Customers Respond to Middle East Impacts
-
The Onyx Realty Group Joins The Real Brokerage
-
Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of STAR-001
-
TWO and CrossCountry Mortgage Announce Definitive Merger Agreement
-
Ford Issues 2026 Proxy Statement, Sets Virtual Annual Meeting for May 14
-
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
-
Kontrol Technologies Increases Its Solutions for the Multi-Residential Building Sector and Enters into Non-Binding Letter of Intent to Acquire HVAC Service Business
-
Askey and Canoga Perkins Announce Strategic Collaboration at MWC Barcelona to Deliver Rapid-Deploy 5G Critical Communications Solutions
-
Vertical Aerospace Selects Isoclima as Strategic Transparency Partner for Valo
-
Qumulo Selects Ireland for European Software Research and Development Hub
-
Greenland Resources Signs MOU With German Dillinger for Molybdenum Supply
-
Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD
-
Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026
-
SSR Mining Announces Normal Course Issuer Bid
-
Formentera and INPEX Announce Strategic Partnership to Accelerate Development of Australia’s Beetaloo Shale Resources
-
Forgent Power Solutions Announces Pricing of Public Offering of Class A Common Stock
-
Re: Notice of Meeting and Definitive Proxy Statement for 2026 Annual General Meeting
-
SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results
-
M1X Global Announces Public Launch and Oversubscribed $3 Million Angel Round to Scale On-Chain Sovereign Finance
-
NIQ Redefines Packaging Intelligence with Monthly, Harmonized Global Performance Visibility
-
Tikehau Capital: Disclosure of Shares Repurchases From 20 March 2026 to 26 March 2026
-
TITAN Group Published the 2025 Integrated Annual Report
-
“MoN Takanawa: The Museum of Narratives” Opens in Tokyo
-
Two Keepit Channel Executives Recognized as 2026 CRN EMEA Channel Leaders
-
Aperture Investors European Innovation Fund Wins 2026 LSEG Lipper Fund Awards
-
European DataWarehouse Claims Its First “Fintech Provider of the Year” Award and a Sixth “Data Provider of the Year” Title at GlobalCapital’s 2026 European Securitisation Awards
-
Tineco Recognised as the World’s Leading Manufacturer of Wet & Dry Vacuum Cleaners for the Fourth Consecutive Year
-
Mexedia Among the Leading Teams at Race for the Cure 2026
-
Vetoquinol: 2025 Annual Results
-
GenSight Biologics Reports Estimated Full-Year Consolidated Financial Results for 2025
-
3D Investment Partners Discloses materials that organize in detail the process by which the Toho HD Audit and Supervisory Committee reached its decision not to start litigation, and that point out the
-
ABIONYX Pharma Achieves Major Milestone in apoA-I Biomanufacturing with Breakthrough in Synthetic Sphingomyelin Production
-
Polish Investment and Trade Agency (PAIH) Names Ascend Elements’ Project Apex 2 Manufacturing Investment of the Year
-
Nidec Announces the Future Nomination of Director Candidates for New Nidec
-
Entertainment Industry Veterans Launch Unified Production Platform (UPP)
-
NTT Solmare and Good Smile Company Announce Strategic Partnership for New Visual Novel "Obey Me! Sinner's Choice"; Wishlist Now on Steam
-
Long Bridge Medical Receives Clearance from FDA to Initiate U.S. Pivotal Clinical Study for LensOne Prosthetic Capsular Bag
-
Faraday Future Completes Delivery of Additional EAI Robots to New PBB Auto Inc., and Showcases Its Robotics to Students in Los Angeles Through an Innovative Hands-on Interactive Demonstration Event
-
Go Behind the Science During Fusion Energy Week: Tour the DIII-D National Fusion Facility, the Nation’s Largest Operating Fusion Device, and See the Future of Energy in Action
-
Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors
-
Krug Promoted to Executive Vice President and Enterprise Operations Executive
-
Pernod Ricard Confirms Discussions With Brown-Forman
-
Brown-Forman Confirms Discussions With Pernod Ricard
-
Westaim Reports Q4 2025 Results For the Quarter and Year Ended December 31, 2025
-
Equity Bancshares, Inc. Will Announce First Quarter 2026 Results on April 14, 2026
-
Veolia Environnement: Availability of the 2025 Universal Registration Document / Annual Financial Report (English Version)
-
Long Bridge Medical Receives Clearance from FDA to Initiate the U.S. Pivotal Clinical Study for LensOne Prosthetic Capsular Bag
-
RH Announces the Appointment of David Stanchak as Chief Real Estate and Transformation Officer
-
The Brand Agency Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
-
Rio Tinto boosts 2025 Australian supplier spend to record A$19.7 billion
